• 1
    Huang S (1999) The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. Front Biosci 4, D528D532.
  • 2
    Huang S (1994) Blimp-1 is the murine homolog of the human transcriptional repressor PRDI-BF1. Cell 78, 9.
  • 3
    Buyse I, Shao G & Huang S (1995) The retinoblastoma protein binds to RIZ, a zinc finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 92, 44674471.
  • 4
    Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J & Morishita K (2000) A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96, 32093214.
  • 5
    Hoyt PR, Bartholomew C, Davis AJ, Yutzey K, Gomer LM, Potter SS, Ihle JN & Mucenski ML (1997) The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev 65, 5570.
  • 6
    Bartholomew C, Kilbey A, Clark A-M & Walker M (1997) The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation. Oncogene 14, 569577.
  • 7
    Kurokawa M, Mitani K, Irie K, Matsuyama T, Takahashi T, Chiba S, Yazaki Y, Matsumoto K & Hirai H (1998) The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature 394, 9296.
  • 8
    Alliston T, Ko TC, Cao Y, Liang YY, Feng XH, Chang C & Derynck R (2005) Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem 280, 2422724237.
  • 9
    Kurokawa M, Mitani K, Yamagata T, Takahashi T, Izutsu K, Ogawa S, Moriguchi T, Nishida E, Yazaki Y & Hirai H (2000) The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. EMBO J 19, 29582968.
  • 10
    Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB & Ihle JN (1992) Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300–400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 89, 39373941.
  • 11
    Kilbey A, Stephens V & Bartholomew C (1999) Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts. Cell Growth Differ 10, 601610.
  • 12
    Kurokawa M, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte ON & Hirai H (1995) The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence. Oncogene 11, 833840.
  • 13
    Kilbey A & Bartholomew C (1998) Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts. Oncogene 16, 22872291.
  • 14
    Palmer S, Brouillet J-P, Kilbey A, Fulton R, Walker M, Crossley M & Bartholomew C (2001) Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J Biol Chem 276, 2583025840.
  • 15
    Izutsu K, Kurokawa M, Imai Y, Maki K, Mitani K & Hirai H (2001) The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood 97, 28152822.
  • 16
    Morishita K, Parganas E, Douglass EC & Ihle JN (1990) Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 5, 963971.
  • 17
    Alzuherri H, McGilvray R, Kilbey A & Bartholomew C (2006) Conservation and expression of a novel alternatively spliced Evi1 exon. Gene 383, 154162.
  • 18
    Bannasch D & Schwab M (1999) A versatile bait vector allowing rapid isolation of prey vectors in Gal4-dependent yeast two-hybrid screens. Plasmid 42, 139143.
  • 19
    Kozak M (1989) The scanning model for translation: an update. J Cell Biol 108, 229.
  • 20
    Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG & Ihle JN (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54, 831840.
  • 21
    Senyuk V, Chakraborty S, Mikhail FM, Zhao R, Chi Y & Nucifora G (2002) The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene 21, 32323240.
  • 22
    Liu Y, Chen L, Ko TC, Fields AP & Thompson EA (2006) Evi1 is a survival factor which conveys resistance to both TGFβ- and taxol-mediated cell death via P13K/AKT. Oncogene 25, 35653575.
  • 23
    Yuasa H, Oike Y, Iwama A, Nishikata I, Sugiyama D, Perkins A, Mucenski ML, Suda T & Morishita K (2005) Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J 24, 19761987.
  • 24
    Schröer A, Schneider S, Ropers H & Nothwang HG (1999) Cloning and characterization of UXT, a novel gene in human Xp11, which is widely and abundantly expressed in tumor tissue. Genomics 56, 340343.
  • 25
    Dastugue N, Duchayne E, Kuhlein E, Rubie H, Demur C, Aurich J, Robert A & Sie P (1997) Acute basophilic leukaemia and translocation t(X;6)(p11;q23). Br J Haematol 98, 170176.
  • 26
    Liu L & McKeehan WL (2002) Sequence analysis of LRPPRC and its SEC1 domain interaction partners suggests roles in cytoskeletal organization, vesicular trafficking, nucleocytosolic shuttling, and chromosome activity. Genomics 79, 124136.
  • 27
    Liu L, Vo A, Liu G & McKeehan WL (2002) Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor RASSF1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cells. In Vitro C ell Dev Biol Anim 38, 582594.
  • 28
    Markus SM, Taneja SS, Logan SK, Li W, Ha S, Hittelman AB, Rogatsky I & Garabedian MJ (2002) Identification and characterization of ART-27, a novel coactivator for the androgen receptor N-terminus. Mol Biol Cell 13, 670682.
  • 29
    Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ & Logan SK (2004) ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem 279, 1394413952.
  • 30
    Zhao H, Wang Q, Zhang H, Du Liu QX, Richiter M & Greene MI (2005) UXT is a novel centrosomal protein essential for cell viability. Mol Biol Cell 16, 58575865.
  • 31
    Weinmann AS, Yan PS, Oberley MJ, Huang TH & Farnham PJ (2002) Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 16, 235244.
  • 32
    Oberley MJ, Inman DR & Farnham PJ (2003) E2F6 negatively regulates BRCA1in human cancer cells without methylation of histone H3 on lysine 9. J Biol Chem 278, 4246642476.
  • 33
    Gstaiger M, Luke B, Hess D, Oakeley EJ, Wirbelauer C, Blondel M, Vigneron M, Peter M & Krek W (2003) Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science 302, 12081212.
  • 34
    Anderson SJ, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA & Mann M (2003) Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426, 570574.
  • 35
    Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • 36
    Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ & Kato JY (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14, 20662076.